ARCHIVES

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

Q&A With The Cancer Letter: MD Anderson Provost Had No Say

May 25, 2012

SEC Notifies ImClone It May Bring Action Against Company

June 21, 2002

In Brief: Everson, Clarke New ACCC Leaders; Katterhagen To Move To Burbank; Vote On Healy Expected

March 22, 1991

New System Devised To Help Identify Emerging Comprehensive Centers

October 10, 1975

Cancer Prevention: Review Group’s Report Urges Integration Of Prevention with all NCI Research

June 27, 1997

Also M.D. Anderson awarded three new, one renewal SPORE grant.

October 31, 2003